Abstract
Endothelial injury represents a major initiating step in the pathogenesis of vascular disease and atherosclerosis. The identification and quantification of circulating endothelial cells (CECs) has evolved as a novel marker of endothelial function. As a technique, it correlates with other markers of endothelial function such as flow-mediated dilation, the measurement of von Willebrand factor, and tissue plasminogen activator. Quantification of CECs is difficult due to low numbers, variable morphology, and a lack of standardization in current techniques used. CECs appear to be a different population of cells to endothelial progenitor cells. Increased CECs have been noted in a number of disease states and is evolving as a novel method of assessment of both disease severity and response to treatment.
Original language | English |
---|---|
Pages (from-to) | 211-24 |
Number of pages | 14 |
Journal | Methods in Molecular Medicine |
Volume | 139 |
Publication status | Published - 1 Jan 2007 |